Page last updated: 2024-08-17

carbostyril and Deafness, Transitory

carbostyril has been researched along with Deafness, Transitory in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casselbrant, ML; Chonmaitree, T; Cripps, AW; Haggard, MP; Rosenfeld, RM; Schilder, AG; Venekamp, RP	1
Choi, JW; Hwang, HS; Jung, YS; Kang, SU; Kim, CH; Lee, BH; Shin, YS; Song, SJ	1
Anniko, M; Ohtani, M; Takumida, M	1

Reviews

1 review(s) available for carbostyril and Deafness, Transitory

Article	Year
Otitis media. Nature reviews. Disease primers, 2016, 09-08, Volume: 2 Topics: Hearing Loss; Humans; Middle Ear Ventilation; Otitis Media; Otoscopy; Pain; Quinolones; Risk Factors; Tympanic Membrane	2016

Trials

1 trial(s) available for carbostyril and Deafness, Transitory

Article	Year
Radical scavengers for Ménière's disease after failure of conventional therapy: a pilot study. Acta oto-laryngologica, 2003, Volume: 123, Issue:6 Topics: Adult; Aged; Alanine; Antioxidants; Ascorbic Acid; Female; Free Radical Scavengers; Glutathione; Hearing Loss; Humans; Male; Meniere Disease; Middle Aged; Pilot Projects; Quinolones; Tinnitus; Treatment Failure; Vertigo	2003

Other Studies

1 other study(ies) available for carbostyril and Deafness, Transitory

Article	Year
A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study. Neuroscience, 2013, Mar-01, Volume: 232 Topics: Animals; Apoptosis; Caspase 3; Cell Line; Cisplatin; Evoked Potentials, Auditory, Brain Stem; Extracellular Signal-Regulated MAP Kinases; Female; Hearing Loss; Membrane Potential, Mitochondrial; Mice; NADPH Oxidases; Neuroprotective Agents; Organ of Corti; Quinolones; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Zebrafish	2013

Article

Year

A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.

Neuroscience, 2013, Mar-01, Volume: 232

Topics: Animals; Apoptosis; Caspase 3; Cell Line; Cisplatin; Evoked Potentials, Auditory, Brain Stem; Extracellular Signal-Regulated MAP Kinases; Female; Hearing Loss; Membrane Potential, Mitochondrial; Mice; NADPH Oxidases; Neuroprotective Agents; Organ of Corti; Quinolones; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Zebrafish

2013